Please select the option that best describes you:
Topics:
Medical Oncology • Internal Medicine • Rheumatology • Hematology • General Rheumatology • VEXAS
For patients with VEXAS syndrome and good response to azacitidine, what duration of therapy do you consider?
How do you decide to trial a patient off treatment? When do you consider spacing therapy and at what frequency?
Answer from: at Community Practice
The short answer: as long as azacitidine is controlling inflammation, reducing/eliminating steroid dependence, and/or improving cytopenias, keep using it. Don't stop (or if the patient is being bridged to alloSCT, continue until BMT).The long answer:VEXAS is an autoinflammatory disease wherein patie...
Sign in or Register to read more